Bacteria with improved metabolic capacity

Abstract

E. coli bacteria comprising genetic modifications to enhance fermentability and production of protein and nucleic acids are provided.

What is claimed is: 
     
         1 . A modified  Escherichia coli  K-12 strain, wherein said strain is modified so as to:
 (a) enhance orotate phosphoribosyltransferase activity;   (b) produce active acetohydroxy acid synthase; and   (c) reduce expression of the isocitrate lyase (iclR) and ankyrin repeat protein A (arpA) gene products; and   (d) lack a functional dinB (b0231) gene.   
     
     
         2 . The modified  E. coli  K-12 strain according to  claim 1 , wherein orotate phosphoribosyltransferase activity is enhanced by the introduction of a mutation which complements a native −1 frameshift mutation in the Ribonuclease PH (rph) gene or by deletion of the rph gene. 
     
     
         3 . The modified  E. coli  K-12 strain according to  claim 1 , wherein active acetohydroxy acid synthase II is produced by the introduction of a mutation which complements a native −2 frameshift mutation in the valine-insensitive acetohydroxy synthase II large subunit (ilvG) gene. 
     
     
         4 . The modified  E. coli  K-12 strain according to  claim 1 , wherein expression of the isocitrate lyase (iclR) and ankyrin repeat protein A (arpA) gene products are reduced by deletion of all or part of the iclR and arpA genes. 
     
     
         5 . The modified  E. coli  K-12 strain according to  claim 1 , wherein the strain lacks a functional recombination protein A (recA) (b2699) gene. 
     
     
         6 . The modified  E. coli  K-12 strain according to  claim 1 , wherein the modified  E. coli  K-12 strain is a modified MG1655, W3110, DH1, DH10B, DH5α, Invα, Top10, Top 10F, JM103, JM105, JM109, MC1061, MC4100, XL1-Blue, EC100, BW2952, or EC300 strain. 
     
     
         7 . The modified  E. coli  K-12 strain of  claim 6 , wherein the modified  E. coli  K-12 strain is a modified  E. coli  K-12 strain MG1655 or W3110 strain. 
     
     
         8 . The modified  E. coli  K-12 strain of  claim 1 , wherein the modified  E. coli  K-12 strain is genetically engineered to be from about 2% to about 25% smaller than  E. coli  strain MG1655. 
     
     
         9 . The modified  E. coli  K-12 strain of  claim 8 , wherein the modified  E. coli  K-12 strain is genetically engineered to be about 14.1% to about 25% smaller than  E. coli  strain MG1655 by deletion of at least the genes deleted from reduced genome  E. coli  strain MDS42. 
     
     
         10 . The modified  E. coli  K-12 strain of  claim 8 , wherein the modified  E. coli  K-12 strain is genetically engineered to be about 20.3% to about 25% smaller than  E. coli  strain MG155 by deletion of at least the genes deleted from reduced genome  E. coli  strain MDS69. 
     
     
         11 . The modified  E. coli  K-12 strain of  claim 9 , wherein the modified  E. coli  K-12 strain is produced by modifying reduced genome  E. coli  strain MDS42. 
     
     
         12 . The modified  E. coli  K-12 strain of  claim 1 , wherein the strain encodes a relaxed (relA) gene having at least one point mutation at position 547 or 548 of the coding sequence of the relA gene, wherein the mutation is selected from one or more of: a G→A mutation at position 547, a G→T mutation at position 547, a C→G mutation at position 548, or a C→T mutation at position 548. 
     
     
         13 . The modified  E. coli  K-12 strain of  claim 1 , wherein the strain lacks functional DNA polymerase V (umuDC) (b1183-b184) and/or DNA polymerase II (polB) (b0060) genes. 
     
     
         14 . The bacterium of  claim 1  comprising a heterologous nucleic acid. 
     
     
         15 . The bacterium of  claim 14 , wherein said heterologous nucleic acid comprises a nucleic acid encoding a polypeptide operatively linked to an expression control sequence. 
     
     
         16 . A method for producing a polypeptide comprising incubating the bacterium of  claim 15  under conditions suitable for expressing the polypeptide and collecting the polypeptide. 
     
     
         17 . The modified  E. coli  K-12 strain of  claim 1 , wherein (i) the strain is modified to enhance orotate phosphoribosyltransferase activity by deletion of the rph gene (ii) the strain is modified to produce active acetohydroxy acid synthase II by the introduction of a mutation which complements a native −2 frameshift mutation in the ilvG gene: (iii) the strain is modified to reduce expression of the iclR and arpA gene products by deletion of the iclR and arpA genes; and (iv) the strain is modified to lack a functional dinB gene. 
     
     
         18 . The modified  E. coli  K-12 strain of  claim 17 , wherein the strain lacks a functional recA (b2699) gene.